In Reply

Corsa P. , Parisi S. , Raguso A. , Troiano M. , Perrone A. , Cossa S. , Munafò T. , Piombino M. , Spagnoletti G. , Borgia F. : Temozolomide and radiotherapy as first-line treatment of high-grade gliomas. Tumori, 92: 299–305, 2006.

Stupp R. , Dietrich P.Y. , Ostermann Kraljevic S. , Pica A. , Maillard I. , Maeder P. , Meuli R. , Janzer R. , Pizzolato G. , Miralbell R. , Porchet F. , Regli L. , de Tribolet N. , Mirimanoff R.O. , Leyvraz S. : Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide. J Clin Oncol, 20: 1375–82, 2002.

Stupp R. , Mason W.P. , van den Bent M.J. , Weller M. , Fisher B. , Taphoorn M.J. , Belanger K. , Brandes A.A. , Marosi C. , Bogdahn U. , Curschmann J. , Janzer R.C. , Ludwin S.K. , Gorlia T. , Allgeier A. , Lacombe D. , Cairncross J.G. , Eisenhauer E. , Mirimanoff R.O. ; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med, 352: 987–996, 2005.

Brandes A.A. : State-of-the-art treatment of high-grade brain tumors. Semin Oncol, 30: 4–9, 2003.